Description

Aflubin (Aconitum D6) Oral Drops 50 ml

Ingredients

Aflubin oral drops contain Aconitum napellus D6, Bryonia cretica D6, Eupatorium perfoliatum D2, and Lachesis muta D12.

Dosage

For adults and children over 12 years: Take 10 drops 3 times a day. For children 6 to 12 years: Take 5 drops 3 times a day. For children 1 to 6 years: Take 3-5 drops 3 times a day. For infants under 1 year: Consult a healthcare practitioner.

Indications

Aflubin oral drops are indicated for the relief of flu-like symptoms such as fever, chills, body aches, and fatigue. It helps reduce the duration and severity of symptoms associated with the flu.

Contraindications

Do not use Aflubin oral drops if you are allergic to any of the ingredients or if you have a known sensitivity to plants of the Ranunculaceae family.

Directions

Shake the bottle before use. Take the drops orally, either directly or diluted in a small amount of water. Avoid eating or drinking 15 minutes before and after taking the drops.

Scientific Evidence

Aconitum napellus, the main ingredient in Aflubin, has been studied for its anti-inflammatory and immunomodulatory effects. Research published in the journal “Phytomedicine” suggests that Aconitum napellus may help reduce inflammation and alleviate symptoms of respiratory infections.

Additional Information

Aflubin oral drops have been used for years in Europe as a natural remedy for flu symptoms. The combination of ingredients works synergistically to support the body’s immune response and promote faster recovery. Consult a healthcare professional before using this product, especially if you have underlying health conditions or are pregnant.

Pharmacological Effects: Aconitum napellus in Aflubin is believed to exert its effects by stimulating the body’s defense mechanisms, helping to combat viral infections and reduce the intensity of flu symptoms.

Clinical Trials: Clinical trials evaluating the efficacy of Aflubin have shown promising results in reducing the duration and severity of flu symptoms compared to a placebo. Further research is ongoing to explore its full potential in managing influenza.